| Financial Year |
March 31 2023 |
| Monetary Funds |
249,074,580.77 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
25,763,510.80 |
| Accounts Receivable |
1,651,673,514.16 |
| Advances to Suppliers |
731,123,141.20 |
| Other Receivables |
122,957,858.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
480,318,751.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
470,606,069.46 |
| Total Current Assets |
3,731,517,426.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
282,868,976.40 |
| Investment Properties |
106,073,116.17 |
| Fixed Assetes |
15,154,398,752.43 |
| Under-construction Projects |
8,639,254,477.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
628,329,593.34 |
| R&D expenses |
-- |
| Goodwill |
838,524,950.63 |
| Long-Term Deferred and Prepaid Expenses |
46,256,224.99 |
| Deferred Income Tax Assets |
164,386,831.57 |
| Other Non-Current Assets |
1,789,444,262.76 |
| Sub-Total of Non-Current Assets |
28,075,612,381.67 |
| Total Assets |
31,807,129,808.05 |
| Short-Term Loans |
5,013,434,715.26 |
| Trading Financial liabilities |
-- |
| Notes Payable |
777,461,101.85 |
| Accounts Payable |
1,519,978,322.27 |
| Accounts Received In Advance |
1,630,552.00 |
| Employee Compensation Payable |
108,744,862.78 |
| Taxes Payable |
230,033,868.40 |
| Interest Payable |
-- |
| Dividend Payable |
676,156.12 |
| Other payables |
540,798,110.24 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,197,689,930.32 |
| Other Current Liabilities |
3,592,174.98 |
| Sub-Total of Current Liabilities |
9,493,289,091.97 |
| Long-term Loans |
11,674,824,843.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,603,046.54 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
55,792,864.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
12,204,202,534.23 |
| Total Liabilities |
21,697,491,626.20 |
| Paid-In Capital(Or Share Stock) |
2,749,327,699.00 |
| Capital Surplus |
3,246,387,377.34 |
| Surplus Reserve |
233,665,645.52 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,609,734,388.96 |
| Minority Stockholder's Interest |
263,856,134.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,845,782,047.02 |
| Owner's Equity（Stockholder's Equity） |
10,109,638,181.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
31,807,129,808.05 |
